Peptide Research Database

🔬 Peptide Compound Directory

Browse full dossiers for peptide compounds. Each dossier includes 3 progressive layers: plain-English analogies, Reddit real-world scorecards, reference dosing ladders, side-effect mitigations, visual syringe calculators, and molecular pharmacokinetics.

Category:

Route:

Found 13 matching peptide compound dossiers

Research Chemical (RUO)t½: ~ 4 - 6 hours

BPC-157

Microvascular Angiogenesis & Connective Tissue Repair Foundation

Community-reported context

Reported onset: First improvements within 5-7 days

SubQ InjectionOralNasal Spray

VEGFR2 (Vascular Endothelial Growth Factor Receptor 2)View Dossier

FDA Approvedt½: ~ 5.0 days

Tirzepatide

Dual GLP-1/GIP Incretin Receptor Co-Agonist & Metabolic Master

Community-reported context

Reported onset: Appetite drops sharply within 24-48 hours of first dose

SubQ Injection

GLP-1R (Glucagon-Like Peptide-1 Receptor)View Dossier

Phase 2 Clinicalt½: ~ 0.5 - 1.0 hour

GHK-Cu

Dermal Type I/III Collagen Remodeling & Follicular Microcirculation Rejuvenation

Community-reported context

Reported onset: Skin radiance improves within 2-3 weeks

SubQ InjectionTopical

TGF-beta Signaling PathwayView Dossier

Phase 2 Clinicalt½: CJC-1295 No DAC ~30 minutes | Ipamorelin ~2 hours

CJC-1295 + Ipamorelin

Pre-Bed Fasted Growth Hormone Pulse Amplifier & Deep Sleep Restorer

Community-reported context

Reported onset: Deep sleep surges within the first week

SubQ Injection

GHRH-R (Growth Hormone Releasing Hormone Receptor)View Dossier

Phase 3 Clinicalt½: Blood half-life ~10-15 minutes

Semax

Potent BDNF Upregulator & Brain Fog Clearing Nootropic Heptapeptide

Community-reported context

Reported onset: Perceptible within 10-15 minutes via nasal spray

Nasal SpraySubQ Injection

BDNF (Brain-Derived Neurotrophic Factor)View Dossier

Phase 3 Clinicalt½: Blood half-life ~10-15 minutes

Selank

Clear-Headed Anxiolytic & GABA-A Modulator with Zero Daytime Sedation

Community-reported context

Reported onset: Inner calm within 10 minutes via nasal spray

Nasal SpraySubQ Injection

GABA-A Receptor Allosteric SitesView Dossier

Phase 2 Clinicalt½: Blood half-life ~tens of minutes

Epithalon

Telomerase Activator & Pineal Circadian Pacemaker Calibration Peptide

Community-reported context

Reported onset: Deep physiological rhythm reset

SubQ InjectionNasal Spray

TERT (Telomerase Reverse Transcriptase Gene Promoter)View Dossier

Phase 3 Clinicalt½: ~ 6.0 days

Retatrutide

Triple GLP-1/GIP/Glucagon Receptor Agonist & Visceral Lipid Thermogenesis Engine

Community-reported context

Reported onset: Accelerated visceral and hepatic lipid clearance

SubQ Injection

GLP-1RView Dossier

FDA Approvedt½: ~ 7.0 days

Semaglutide

Global commonly discussed Single GLP-1 Incretin Weight Management Benchmark

Community-reported context

Reported onset: Noticeable satiety boost in Week 1

SubQ InjectionOral

GLP-1R (Glucagon-Like Peptide-1 Receptor)View Dossier

Research Chemical (RUO)t½: ~ 24 hours

TB-500

Systemic Actin-Mediated Cell Migration & Anti-Fibrotic Tissue Repair

Community-reported context

Reported onset: Observable tissue relief within 1-2 weeks

SubQ Injection

G-Actin (Globular Actin)View Dossier

Phase 2 Clinicalt½: ~ 1 - 2 hours

KPV

Targeted NF-κB Nuclear Blockade & Gastrointestinal Mucosal Anti-Inflammation

Community-reported context

Reported onset: Gut comfort improves within 3-5 days

OralSubQ InjectionTopical

NF-kB Transcription FactorView Dossier

Phase 2 Clinicalt½: ~ 30 minutes

AOD-9604

Targeted Adipocyte Lipolysis & Zero Glycemic/Insulin Disturbance

Community-reported context

Reported onset: Subcutaneous fat thickness decreases in 2-4 weeks

SubQ Injection

beta-3 Adrenergic Receptor SynergyView Dossier

Phase 2 Clinicalt½: ~ 24 hours

MK-677 (Ibutamoren)

Non-Peptide Oral Growth Hormone Secretagogue & Appetite Stimulant

Community-reported context

Reported onset: Surging appetite and deep sleep on Day 1

Oral

GHS-R1a (Growth Hormone Secretagogue Receptor)View Dossier